Earnings Feed
Start Free
Perimeter Solutions, Inc.·4

Mar 2, 5:30 PM ET

Iversen Bernt G II 4

4 · Perimeter Solutions, Inc. · Filed Mar 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Perimeter (PRM) Director Bernt G. Iversen Receives 35,682-Share Award

What Happened

  • Bernt G. Iversen, a director of Perimeter Solutions, reported the acquisition of 35,682 shares on Feb 26, 2026 via the vesting of previously granted stock options/awards. The filing lists six derivative acquisitions (total 35,682 shares) recorded at $0.00 per share, reflecting vested option shares rather than an open-market purchase or cash exercise.

Key Details

  • Transaction date: 2026-02-26; Filing date: 2026-03-02 (filed timely).
  • Price: $0.00 per share — these are vested option/award shares (derivative transactions).
  • Shares vested by grant (vested amounts): 2,655; 6,194; 7,000; 7,000; 7,000; 5,833 (total = 35,682).
  • Shares owned after transaction: not disclosed in the provided filing extract.
  • Footnotes: Vesting resulted from satisfying performance criteria for fiscal-year targets tied to option grants made in 2022–2025 (see individual grant dates in footnotes). No 10b5-1 plan, tax-withholding sale, or immediate cashless sale is indicated in the summary provided.

Context

  • These are derivative/award vesting events (options/awards becoming vested based on performance), which simply convert potential option shares into owned shares—not a buy or sale in the open market. The filing does not indicate any immediate sale of the vested shares. For retail investors, vesting reflects compensation tied to company performance but is not a direct bullish or bearish vote like an open-market purchase or sale.

Insider Transaction Report

Form 4
Period: 2026-02-26
Perimeter Solutions, Inc.PRM
Iversen Bernt G II
Director
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-02-26+2,655→ 2,655 total
    Exercise: $27.84From: 2026-02-26Exp: 2035-12-23→ Common Stock (2,655 underlying)
  • Award

    Stock Option (right to buy)

    [F2]
    2026-02-26+6,194→ 6,194 total
    Exercise: $11.80From: 2026-02-26Exp: 2035-02-12→ Common Stock (6,194 underlying)
  • Award

    Stock Option (right to buy)

    [F3]
    2026-02-26+7,000→ 14,000 total
    Exercise: $5.23From: 2026-02-26Exp: 2034-02-14→ Common Stock (7,000 underlying)
  • Award

    Stock Option (right to buy)

    [F4]
    2026-02-26+7,000→ 21,000 total
    Exercise: $8.88From: 2026-02-26Exp: 2033-02-15→ Common Stock (7,000 underlying)
  • Award

    Stock Option (right to buy)

    [F5]
    2026-02-26+7,000→ 21,000 total
    Exercise: $5.50From: 2026-02-26Exp: 2033-09-06→ Common Stock (7,000 underlying)
  • Award

    Stock Option (right to buy)

    [F6]
    2026-02-26+5,833→ 23,333 total
    Exercise: $10.13From: 2026-02-26Exp: 2032-05-03→ Common Stock (5,833 underlying)
Footnotes (6)
  • [F1]On December 23, 2025, the reporting person was granted an option to purchase 15,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 2,655 shares of common stock.
  • [F2]On February 12, 2025, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 6,194 shares of common stock.
  • [F3]On February 14, 2024, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock.
  • [F4]On February 15, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock.
  • [F5]On September 6, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock.
  • [F6]On May 3, 2022, the reporting person was granted an option to purchase 29,167 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 5,833 shares of common stock.
Signature
/s/ Noriko Yokozuka, as Attorney-in-Fact|2026-03-02

Documents

1 file
  • 4
    wk-form4_1772490637.xmlPrimary

    FORM 4